Hepatic resection for hepatocellular carcinoma in severely cirrhotic livers

Hepato-Gastroenterology

Volumn 50, Issue 50, 2003, Pages 491-496

  Kaibori, Masaki ^a   Matsui, Yoichi ^a   Kitade, Hiroaki ^a   Kwon, A Hon ^a   Kamiyama, Yasuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cirrhosis; Hepatectomy; Hepatocellular carcinoma; Indocyanine green 15 minute retention rate; Transcatheter arterial chemoembolization

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; EMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; RETROSPECTIVE STUDIES;

EID: 0037351802     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Ganne-Carie N, Chastang C, Chapel F, et al: Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in western patients with cirrhosis. Hepatology 1996; 23:1112-1118.
2. Nagasue N, Kohno H, Chang YC, et al: Liver resection for hepatocellular carcinoma. Ann Surg 1993; 217:375-384.
3. Livraghi T, Giorgio A, Marin G, et al: Hepatocellular carcinoma and cirrhosis in 746 patients: Long-term results of percutaneous ethanol injection. Radiology 1995; 197:101-108.
4. Ikeda K, Kumada H, Saitoh S, et al: Effect of repeated transcatheter arterial embolization on the survival time in patients with hepatocellular carcinoma. Cancer 1991; 68:2150-2154.
5. Bismuth H, Chiche L, Adam R, et al: Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg 1993; 210:145-151.
6. Mor E, Kaspa RT, Sheiner P, et al: Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 1998; 129:643-653.
7. Fujio N, Sakai K, Kinoshita H, et al: Results of treatment of patients with hepatocellular carcinoma with severe cirrhosis of the liver. World J Surg 1989; 13:211-218.
8. Arii S, Yamaoka Y, Futagawa S, et al: Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan. Hepatology 2000; 32:1224-1229.
9. Makuuchi M, Kosuge T, Takayama T, et al: Surgery for small liver cancers. Semin Surg Oncol 1993; 9:298-304.
10. Wu CC, Yeh DC, Lin MC, et al: Improving operative safety for cirrhotic liver resection. Br J Surg 2001; 88:210-215.
11. Yasui M, Harada A, Torii A, et al: Impaired liver function and long-term prognosis after hepatectomy for hepatocellular carcinoma. World J Surg 1995; 19:439-443.
12. Hemming AW, Scudamore CH, Shackleton CR, et al: Indocyanine green clearance as a predictor of successful hepatic resection in cirrhotic patients. Am J Surg 1992; 163:515-518.
13. Kwon AH, Ha-Kawa SK, Uetsuji S, et al: Preoperative determination of the surgical procedure for hepatectomy using technetium-99m-galactosyl human serum albumin (99mTc-GSA) liver scintigraphy. Hepatology 1997; 25:426-429.
14. Child CG, Turcotte JG: Surgery and portal hypertension. In: Child CG (Ed.). The liver and portal hypertension. Philadelphia: WB Sanders, 1964; pp. 48-51.
15. Tabuse K, Katsumi M, Kobayashi Y, et al: Microwave surgery: Hepatecomy using a microwave tissue coagulator. World J Surg 1985; 9:136-143.
16. Ryu M, Watanabe K, Yamamoto H: Hepatectomy with microwave tissue coagulation for hepatocellular carcinoma. J Hep Bil Pancr Surg 1998; 5:184-191.
17. Couinaud C: Etudes Anatomiques et Chirugicales. Paris: Mason, 1957.
18. Hermanek P, Sobin LH: International union against cancer: TNM classification of malignant tumors Berlin: Springer-Verlag, 1992; pp. 59-61.
19. Wu CC, Hwang CR, Liu TJ, et al: Effects and limitations of prolonged intermittent ischaemia for hepatic resection of the cirrhotic liver. Br J Surg 1996; 83:121-124.
20. Morimoto Y, Nishida T, Kamiike W, et al: Insulin pretreatment protects the liver from ischemic damage during Pringle's maneuver. Surgery 1996; 120:808-815.
21. Chen MF, Hwang TL, Jeng LB, et al: Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years. Arch Surg 1994; 129:738-742.
22. Nonami T, Harada A, Kurokawa T, et al: Hepatic resection for hepatocellular carcinoma. Am J Surg 1997; 173:288-291.
23. Sugioka A, Tsuzuki T, Kanai T: Postresection prognosis of patients with hepatocellular carcinoma. Surgery 1993; 113:612-618.
24. Chau GY, Lui WY, Tsay SH, et al: Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Child's A patients. J Surg Oncol 1997; 66:122-126.
25. Kosuge T, Makuuchi M, Takayama T, et al: Long-term results after resection of hepatocellular carcinoma: experience of 480 cases. Hepatogastroenterology 1993; 40:328-332.
26. Fuster J, Garcia-Valdecasas JC, Grande L, et al: Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg 1996; 223:297-302.
27. Yamamoto J, Kosuge T, Takayama T, et al: Recurrence of hepatocellular carcinoma after surgery. Br J Surg 1996; 83:1219-1222.
28. Izumi R, Shimizu K, Ii T, et al: Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994; 106:720-727.
29. Jwo SC, Chiu JH, Chau GY, et al: Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology 1992; 16:1367-1371.
30. Adachi E, Maeda T, Matsumata T, et al: Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology 1995; 108:768-775.
31. Ko S, Nakajima Y, Kanehiro H, et al: Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy. Results of multivariate analysis. Ann Surg 1996; 224:591-595.
32. Yoshida Y, Kanematsu T, Matsumata T, et al: Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection. Ann Surg 1989; 209:297-301.
33. Yamada R, Sato M, Kawabata M, et al: Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology 1983; 148:397-401.
34. Sato Y, Fujiwara K, Ogata I, et al: Transcatheter arterial embolization for hepatocellular carcinoma: benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments. Cancer 1985; 55:2822-2825.
35. Uchida M, Kohno H, Kubota H, et al: Role of preoperative transcatheter arterial oily chemoembolization for resectable hepatocellular carcinoma. World J Surg 1996; 20:326-331.
36. Adachi E, Matsumata T, Nishizaki T, et al: Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer 1993; 72:3593-3598.
37. Majno PE, Adam R, Bismuth H, et al: Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226:688-703.
38. Wu CC, Ho YZ, Ho WL, et al: Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 1995; 82:122-126.